The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9
Open accessAbstract
Transcriptional deregulation through the production of dominant-acting chimeric transcription factors derived from chromosomal translocations is a common theme in the pathogenesis of acute leukemias; however, the essential target genes for acute leukemogenesis are unknown. We demonstrate here that primary myeloid progenitors immortalized by various MLL oncoproteins exhibit a characteristic Hoxa gene cluster expression profile, which reflects that preferentially expressed in the myeloid clonogenic progenitor fraction of normal bone marrow. Continued maintenance of this MLL-dependent Hoxa gene expression profile is associated with conditional MLL-associated myeloid immortalization. Moreover, Hoxa7 and Hoxa9 were specifically required for efficient in vitro myeloid immortalization by an MLL fusion protein but not other leukemogenic fusion proteins. Finally, in a bone marrow transduction/transplantation model, Hoxa9 is essential for MLL-dependent leukemogenesis in vivo, a primary requirement detected at the earliest stages of disease initiation. Thus, a genetic reliance on Hoxa7 and Hoxa9 in MLL-mediated transformation demonstrates a gain-of-function mechanism for MLL oncoproteins as upstream constitutive activators that promote myeloid transformation via a Hox-dependent mechanism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Yeoh, E.-J., Ross, M. E., Shurtleff, S. A., Williams, W. K., Patel, D., Mahfouz, R., Behm, F. G., Raimondi, S. C., Relling, M. V., Patel, A., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00032-6 · Cited by 1,917
MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia
Armstrong, S. A., Staunton, J. E., Silverman, L. B., Pieters, R., den Boer, M. L., Minden, M. D., Sallan, S. E., Lander, E. S., Golub, T. R., & Korsmeyer, S. J. (2002) · Nature Genetics · doi:10.1038/ng765 · Cited by 1,723
The roles of FLT3 in hematopoiesis and leukemia
Gilliland, D. G., & Griffin, J. D. (2002) · Blood · doi:10.1182/blood-2002-02-0492 · Cited by 1,558
Chromosomal translocations in human cancer
Rabbitts, T. H. (1994) · Nature · doi:10.1038/372143a0 · Cited by 1,503
MLL Targets SET Domain Methyltransferase Activity to Hox Gene Promoters
Milne, T. A., Briggs, S. D., Brock, H. W., Martin, M. E., Gibbs, D., Allis, C. D., & Hess, J. L. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00741-4 · Cited by 1,053
Tkachuk, D. C., Kohler, S., & Cleary, M. L. (1992) · Cell · doi:10.1016/0092-8674(92)90602-9 · Cited by 920
Self-citationReversible Tumorigenesis by MYC in Hematopoietic Lineages
Felsher, D. W., & Bishop, J. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80367-6 · Cited by 881
Altered Hox expression and segmental identity in Mll-mutant mice
Yu, B. D., Hess, J. L., Horning, S. E., Brown, G. A. J., & Korsmeyer, S. J. (1995) · Nature · doi:10.1038/378505a0 · Cited by 875
Gu, Y., Nakamura, T., Alder, H., Prasad, R., Canaani, O., Cimino, G., Croce, C. M., & Canaani, E. (1992) · Cell · doi:10.1016/0092-8674(92)90603-a · Cited by 824
Littlewood, T. D., Hancock, D. C., Danielian, P. S., Parker, M. G., & Evan, G. I. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.10.1686 · Cited by 781
Nakamura, T., Mori, T., Tada, S., Krajewski, W., Rozovskaia, T., Wassell, R., Dubois, G., Mazo, A., Croce, C. M., & Canaani, E. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00740-2 · Cited by 721
Nourse, J., Mellentin, J. D., Galili, N., Wilkinson, J., Stanbridge, E., Smith, S. D., & Cleary, M. L. (1990) · Cell · doi:10.1016/0092-8674(90)90657-z · Cited by 662
Self-citationHoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b
Kroon, E., Krosl, J., Thorsteinsdottir, U., Baban, S., Buchberg, A. M., & Sauvageau, G. (1998) · The EMBO Journal · doi:10.1093/emboj/17.13.3714 · Cited by 640
Corral, J., Lavenir, I., Impey, H., Warren, A. J., Forster, A., Larson, T. A., Bell, S., McKenzie, A. N. J., King, G., & Rabbitts, T. H. (1996) · Cell · doi:10.1016/s0092-8674(00)81269-6 · Cited by 522
Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins
Ayton, P. M., & Cleary, M. L. (2001) · Oncogene · doi:10.1038/sj.onc.1204639 · Cited by 500
Self-citationSauvageau, G., Lansdorp, P. M., Eaves, C. J., Hogge, D. E., Dragowska, W. H., Reid, D. S., Largman, C., Lawrence, H. J., & Humphries, R. K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12223 · Cited by 497
A trithorax–like gene is interrupted by chromosome 11q23 translocations in acute leukaemias
Djabali, M., Selleri, L., Parry, P., Bower, M., Young, B. D., & Evans, G. A. (1992) · Nature Genetics · doi:10.1038/ng1092-113 · Cited by 474
Reversibility of acute B-cell leukaemia induced by BCR–ABL1
Huettner, C. S., Zhang, P., Van Etten, R. A., & Tenen, D. G. (2000) · Nature Genetics · doi:10.1038/71691 · Cited by 413
Lavau, C. (1997) · The EMBO Journal · doi:10.1093/emboj/16.14.4226 · Cited by 400
Leukemia and the disruption of normal hematopoiesis
Sawyers, C. L., Denny, C. T., & Witte, O. N. (1991) · Cell · doi:10.1016/0092-8674(91)90643-d · Cited by 343
Thorsteinsdottir, U., Sauvageau, G., Hough, M. R., Dragowska, W., Lansdorp, P. M., Lawrence, H. J., Largman, C., & Humphries, R. K. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.1.495 · Cited by 325
Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias
Nakamura, T., Largaespada, D. A., Shaughnessy, J. D., Jenkins, N. A., & Copeland, N. G. (1996) · Nature Genetics · doi:10.1038/ng0296-149 · Cited by 303
Yu, B. D., Hanson, R. D., Hess, J. L., Horning, S. E., & Korsmeyer, S. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10632 · Cited by 302
Pineault, N., Helgason, C. D., Lawrence, H. J., & Humphries, R. K. (2002) · Experimental Hematology · doi:10.1016/s0301-472x(01)00757-3 · Cited by 282
Chromosome translocations: dangerous liaisons revisited
Rowley, J. D. (2001) · Nature Reviews Cancer · doi:10.1038/35106108 · Cited by 274
Defects in Yolk Sac Hematopoiesis in Mll-Null Embryos
Hess, J. L., Yu, B. D., Li, B., Hanson, R., & Korsmeyer, S. J. (1997) · Blood · doi:10.1182/blood.v90.5.1799 · Cited by 257
Hunger, S. P., Ohyashiki, K., Toyama, K., & Cleary, M. L. (1992) · Genes & Development · doi:10.1101/gad.6.9.1608 · Cited by 239
Self-citationGrowth Disturbance in Fetal Liver Hematopoiesis of Mll-Mutant Mice
Yagi, H., Deguchi, K., Aono, A., Tani, Y., Kishimoto, T., & Komori, T. (1998) · Blood · doi:10.1182/blood.v92.1.108.413k11_108_117 · Cited by 238
Hanson, R. D., Hess, J. L., Yu, B. D., Ernst, P., van Lohuizen, M., Berns, A., van der Lugt, N. M. T., Shashikant, C. S., Ruddle, F. H., Seto, M., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14372 · Cited by 236
NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice
Kroon, E. (2001) · The EMBO Journal · doi:10.1093/emboj/20.3.350 · Cited by 226
Slany, R. K., Lavau, C., & Cleary, M. L. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.122 · Cited by 224
Self-citationDobson, C. L. (1999) · The EMBO Journal · doi:10.1093/emboj/18.13.3564 · Cited by 207
So, C. W., Karsunky, H., Passegué, E., Cozzio, A., Weissman, I. L., & Cleary, M. L. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00019-9 · Cited by 204
Self-citationLavau, C. (2000) · The EMBO Journal · doi:10.1093/emboj/19.17.4655 · Cited by 203
Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia
Drabkin, H., Parsy, C., Ferguson, K., Guilhot, F., Lacotte, L., Roy, L., Zeng, C., Baron, A., Hunger, S., Varella-Garcia, M., et al. (2002) · Leukemia · doi:10.1038/sj.leu.2402354 · Cited by 185
Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4 : 11) abnormality
Rozovskaia, T., Feinstein, E., Mor, O., Foa, R., Blechman, J., Nakamura, T., Croce, C. M., Cimino, G., & Canaani, E. (2001) · Oncogene · doi:10.1038/sj.onc.1204174 · Cited by 181
Schnabel, C. A., Jacobs, Y., & Cleary, M. L. (2000) · Oncogene · doi:10.1038/sj.onc.1203371 · Cited by 150
Self-citationLavau, C., Luo, R. T., Du, C., & Thirman, M. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190167297 · Cited by 140
The AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10
DiMartino, J. F., Ayton, P. M., Chen, E. H., et al. (2002) · Blood · doi:10.1182/blood.v99.10.3780 · Cited by 137
Self-citationCommon mechanism for oncogenic activation of MLL by forkhead family proteins
So, C. W. E., & Cleary, M. L. (2002) · Blood · doi:10.1182/blood-2002-06-1785 · Cited by 119
Self-citationTargeted Mutations inHoxa-9andHoxb-9Reveal Synergistic Interactions
Chen, F., & Capecchi, M. R. (1997) · Developmental Biology · doi:10.1006/dbio.1996.8440 · Cited by 116
DiMartino, J. F., Miller, T., Ayton, P. M., Landewe, T., Hess, J. L., Cleary, M. L., & Shilatifard, A. (2000) · Blood · doi:10.1182/blood.v96.12.3887 · Cited by 105
Self-citationLawrence, H. J., Sauvageau, G., Ahmadi, N., Lopez, A. R., Beau, M. M. L., Link, M., Humphries, R. K., & Largman, C. (1995) · PubMed · Cited by 103
So, C. W. E., & Cleary, M. L. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.18.6542-6552.2002 · Cited by 101
Self-citationChen, F., Greer, J. M., & Capecchi, M. R. (1998) · Mechanisms of Development · doi:10.1016/s0925-4773(98)00126-9 · Cited by 73
Ayton, P. M., Sneddon, S., Palmer, D. B., Rosewell, I. R., Owen, M. J., Young, B. D., Presley, R., & Subramanian, V. (2001) · genesis · doi:10.1002/gene.1066 · Cited by 71
Self-citation
Cited by
Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9
Krivtsov, A. V., Twomey, D., Feng, Z., Stubbs, M. C., Wang, Y., Faber, J., Levine, J. E., Wang, J., Hahn, W. C., Gilliland, D. G., et al. (2006) · Nature · doi:10.1038/nature04980 · Cited by 1,513
Pui, C.-H., Relling, M. V., & Downing, J. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmra023001 · Cited by 1,185
Shilatifard, A. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-051710-134100 · Cited by 1,091
Targeting Metabolism for Cancer Therapy
Luengo, A., Gui, D. Y., & Vander Heiden, M. G. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.08.028 · Cited by 971
“The transcription factor HoxA9 is overexpressed in 70% of AML cases, and overexpression of this transcription factor alone is sufficient to immortalize murine bone marrow derived myeloid cells (Ayton and Cleary, 2003; Golub et al., 1999; Kroon et al., 1998).”
BackgroundSelective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
Daigle, S. R., Olhava, E. J., Therkelsen, C. A., Majer, C. R., Sneeringer, C. J., Song, J., Johnston, L. D., Scott, M. P., Smith, J. J., Xiao, Y., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.009 · Cited by 923
Metadata
- Authors
- Ayton, P. M., & Cleary, M. L.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2003-01-01
- Volume
- 17
- Issue
- 18
- Pages
- 2298-2307
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2158773950
- Cited by
- 436
- References
- 47
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.